Stay updated on Nab-sirolimus in Brain Cancer Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.

Latest updates to the Nab-sirolimus in Brain Cancer Clinical Trial page
- ChecktodayChange DetectedRevision: v3.5.0 was added, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check8 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No study content or functionality is altered.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.4.2 was added and the previous notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe page adds a government funding/status notice and updates to revision v3.4.1, while removing the previous v3.4.0 revision.SummaryDifference0.4%

- Check50 days agoChange DetectedMinor UI and metadata changes: a glossary toggle was added and the footer now displays 'Last Update Submitted that Met QC Criteria' with revision 'v3.4.0', while the previous label 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3. This appears to be a minor version update with no observable changes to study content, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to Nab-sirolimus in Brain Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.